Substituted 1-pyrimidinylacetamide compounds

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 239/47 (2006.01) A61K 31/505 (2006.01) A61K 31/535 (2006.01) A61K 31/675 (2006.01) C07D 239/46 (2006.01) C07D 401/02 (2006.01) C07D 401/04 (2006.01) C07D 401/12 (2006.01) C07D 401/14 (2006.01) C07D 403/02 (2006.01) C07D 405/02 (2006.01) C07D 409/02 (2006.01) C07D 409/04 (2006.01) C07D 409/14 (2006.01) C07D 413/02 (2006.01) C07D 417/02 (2006.01) C07F 9/6512 (2006.01) C07K 5/06 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2076226

The present invention relates to certain novel substituted heterocycles which are 1-pyrimidinylacetamide compounds of formula I, which are inhibitors of human leukocyte elastase (HLE), also known as human neutrophil elastase (HNE), making them useful whenever such inhibition is desired, such as for research tools in pharmacological, diagnostic and related studies and in the treatment of diseases in mammals in which HLE is implicated. The invention also includes intermediates useful in the synthesis of these substituted heterocycles, pharmaceutical compositions containing such substituted heterocycles and methods for their use. The compounds of formula I have the structure: (see formula I) wherein R0 is C1-5alkyl, and R and R6 represent different radicals.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Substituted 1-pyrimidinylacetamide compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Substituted 1-pyrimidinylacetamide compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted 1-pyrimidinylacetamide compounds will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1890995

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.